Article
Oncology
Qi Zou, Xiaolin Wang, Donglin Ren, Bang Hu, Guannan Tang, Yu Zhang, Meijin Huang, Rish K. Pai, Daniel D. Buchanan, Aung Ko Win, Polly A. Newcomb, William M. Grady, Huichuan Yu, Yanxin Luo
Summary: This study developed a DNA methylation-based signature for CD8+ TILs in colorectal cancer, which showed a strong association with prognosis and immune markers. The QASM assay developed for CD8+ MeTIL markers provided a quantitative and accurate measurement of CD8+ TILs distribution in tumor tissues, indicating potential as a biomarker for therapeutic approaches, including immunotherapy.
JOURNAL FOR IMMUNOTHERAPY OF CANCER
(2021)
Article
Oncology
Chong Zhang, Xiang-Yu Wang, Jie-Liang Zuo, Xue-Fu Wang, Xiao-Wen Feng, Bo Zhang, Yi-Tong Li, Chen-He Yi, Peng Zhang, Xiao-Chen Ma, Zhen-Mei Chen, Yue Ma, Jia-Hao Han, Bao-Rui Tao, Rui Zhang, Tian-Qi Wang, Li Tong, Wang Gu, Si-Yu Wang, Xiao-Fei Zheng, Wen-Kang Yuan, Zi-Jie Kan, Jie Fan, Xiang-Yang Hu, Jun Li, Chao Zhang, Jin-Hong Chen
Summary: Tertiary lymphoid structures (TLSs) in colorectal cancer liver metastases (CRCLM) are found to be associated with prognosis. The study analyzed data from 603 CRCLM patients and found that higher intratumor TLSs score is correlated with better prognosis, while higher peritumor TLSs score is correlated with poorer survival. Additionally, the study also found a correlation between immune cell composition within TLSs and TLSs score.
JOURNAL FOR IMMUNOTHERAPY OF CANCER
(2023)
Article
Oncology
Kumiko Hayashi, Daichi Nogawa, Maki Kobayashi, Ayaka Asakawa, Yae Ohata, Shota Kitagawa, Kazuishi Kubota, Hisashi Takahashi, Miyuki Yamada, Goshi Oda, Tsuyoshi Nakagawa, Hiroyuki Uetake, Iichiroh Onishi, Yuko Kinowaki, Morito Kurata, Masanobu Kitagawa, Kouhei Yamamoto
Summary: In breast cancer, tumor infiltrating lymphocytes (TILs) play an important role in cancer immunotherapy. The presence of TILs has been identified as a predictor of response to chemotherapy. However, the relationship between immune profiles and the efficacy of immune checkpoint inhibitors in the tumor microenvironment is unclear. This study quantified the subsets of TILs in breast cancer tissues and compared them among different subtypes, finding that the expression profiles of TILs differ among breast cancer subtypes.
FRONTIERS IN ONCOLOGY
(2022)
Article
Oncology
Ronald Chan, Chaiwat Aphivatanasiri, Ivan K. Poon, Julia Y. Tsang, Yunbi Ni, Maribel Lacambra, Joshua Li, Conrad Lee, Gary M. Tse
Summary: This study investigated the impact of interactions between CD103 TILs and FoxP3 TILs on the prognosis of breast cancer. CD103 TILs were found to be closer to tumor nests than FoxP3 TILs in the tumor-stromal interface. High stromal FoxP3 TIL density and close proximity of CD103 TILs to tumor nests were independently associated with better survival. Subgroup analysis showed that the association between high FoxP3 TIL density and better survival was mainly seen in HER2-OE and TNBC subtypes, while the association between the proximity of CD103 TILs to tumor nests and better survival was mainly seen in luminal cancers.
Article
Oncology
Huanhe Ni, Huanling Zhang, Lin Li, He Huang, Hui Guo, Lin Zhang, Chunwei Li, Jing-Xiao Xu, Cai-Ping Nie, Kui Li, Xiaoshi Zhang, Xiaojun Xia, Jiang Li
Summary: In this study, it was found that increased STING and CCL22 levels, as well as higher levels of FOXP3(+) cells and lower levels of CD8(+) cells in tumor tissues of cervical cancer, predicted poor survival. Activation of STING signaling in cooperation with T cell receptor and other signals promoted iTreg differentiation in both human and murine CD4(+) naive T cells. Additionally, tumor-derived exosomes were found to activate STING signaling in tumor-infiltrated T cells, leading to iTreg expansion.
JOURNAL FOR IMMUNOTHERAPY OF CANCER
(2022)
Article
Immunology
Sarah A. Penny, Jennifer G. Abelin, Stacy A. Malaker, Paisley T. Myers, Abu Z. Saeed, Lora G. Steadman, Dina L. Bai, Stephen T. Ward, Jeffrey Shabanowitz, Donald F. Hunt, Mark Cobbold
Summary: The study found that in colorectal cancer, HLA-I phosphopeptides are important targets for immunotherapy, triggering tumor-resident immunity against malignancy. These phosphopeptides, derived from certain signaling pathways, can potentially lead to the development of broadly applicable therapeutic strategies.
FRONTIERS IN IMMUNOLOGY
(2021)
Review
Biochemistry & Molecular Biology
Imke Atreya, Markus F. Neurath
Summary: The successful treatment of advanced colorectal cancer remains a challenge due to low immunogenicity. Enhancing the accumulation of cytolytic effector T lymphocytes and other cellular mediators is targeted for improved outcomes. Studying the molecular mechanisms and cellular interactions in the tumor microenvironment is crucial for identifying new therapeutic targets.
Article
Immunology
Sandra van Wilpe, Mark A. J. Gorris, Lieke L. van der Woude, Shabaz Sultan, Rutger H. T. Koornstra, Antoine G. van der Heijden, Winald R. Gerritsen, Michiel Simons, I. Jolanda M. de Vries, Niven Mehra
Summary: This study found spatial heterogeneity in advanced urothelial cancer, challenging the use of tumor-infiltrating immune cells as biomarkers for response prediction. Additionally, it suggests a decrease in tumor-infiltrating T cell numbers during chemotherapy.
FRONTIERS IN IMMUNOLOGY
(2022)
Article
Surgery
Yuki Imazu, Yasuko Matsuo, Daisuke Hokuto, Satoshi Yasuda, Takahiro Yoshikawa, Naoki Kamitani, Chieko Yoshida, Toshihide Sasaki, Masayuki Sho
Summary: Tumor-infiltrating lymphocytes (TILs) in both primary and metastatic sites may have prognostic value for colorectal liver metastasis (CRLM). In synchronous CRLM patients, low expression of CD8(+) or CD45RO(+) TILs in the metastatic site was associated with worse overall survival. In metachronous CRLM patients, low expression of CD45RO(+) TILs in the primary site was associated with worse overall survival.
LANGENBECKS ARCHIVES OF SURGERY
(2023)
Review
Immunology
Ziyi Bai, Yao Zhou, Zifan Ye, Jialong Xiong, Hongying Lan, Feng Wang
Summary: The clinical success of immunotherapy has brought attention to tumor-infiltrating lymphocytes (TILs) in different types of cancer. Immune checkpoint blockade is effective in treating metastatic colorectal cancer patients with mismatch repair defects and high microsatellite instability, while patients with proficient mismatch repair and low microsatellite stability have poor response to immune checkpoint inhibitors. Understanding the characteristics of TILs can shed light on the mechanisms of cancer-immune evasion and provide opportunities for novel therapeutic strategies.
FRONTIERS IN IMMUNOLOGY
(2022)
Article
Immunology
Yanping Hu, Jiuzhou Zhao, Yihang Shen, Chengjuan Zhang, Qingxin Xia, Guoqiang Zhang, Bo Wang, Bing Wei, Rentao Yu, Jie Ma, Yongjun Guo
Summary: The study found that CD8 + CD279+ cells are an independent prognostic factor for DFS in CRC patients, with high levels of CD8 + CD279+ cells associated with better DFS.
INTERNATIONAL IMMUNOPHARMACOLOGY
(2022)
Article
Oncology
Minlin Jiang, Chunyan Wu, Liping Zhang, Chenglong Sun, Hao Wang, Yi Xu, Hui Sun, Jun Zhu, Wencheng Zhao, Qiyu Fang, Jia Yu, Peixin Chen, Shengyu Wu, Zixuan Zheng, Yayi He, Caicun Zhou
Summary: The study found that FOXP3 in SCLC is associated with immune biomarkers like PD-L1, PD-1, CD4, CD8, and CD3, and is correlated with longer relapse-free survival. An immune risk score model incorporating FOXP3, TIL PD-L1, and CD8 showed better predictive performance than single or two-indicator-based systems.
JOURNAL FOR IMMUNOTHERAPY OF CANCER
(2021)
Article
Oncology
En Wang, Masatsune Shibutani, Hisashi Nagahara, Tatsunari Fukuoka, Yasuhito Iseki, Yuki Okazaki, Shinichiro Kashiwagi, Hiroaki Tanaka, Kiyoshi Maeda
Summary: The study investigated the relationship between TIL infiltration and prognosis in patients with colorectal cancer liver metastases, finding that CD8(+)TIL infiltration was significantly associated with recurrence and overall survival. In patients without preoperative chemotherapy, CD8(+)TIL infiltration was significantly associated with recurrence-free survival, with a higher presence of CD8(+)TILs having a better effect on overall survival. However, in the long-term chemotherapy group, the degree of TIL infiltration was not necessarily associated with prognosis.
Article
Pathology
Stephan Ledderose, Severin Rodler, Lennert Eismann, Georg Ledderose, Carola Ledderose
Summary: The degree of stromal tumor-infiltrating lymphocytes (sTILs) can reliably predict survival in patients with muscle-invasive urinary bladder cancer (MIBC).
PATHOLOGY RESEARCH AND PRACTICE
(2022)
Article
Oncology
Qiaoqi Sui, Dingxin Liu, Wu Jiang, Jinghua Tang, Lingheng Kong, Kai Han, Leen Liao, Yuan Li, Qingjian Ou, Binyi Xiao, Guochen Liu, Yihong Ling, Jiewei Chen, Zexian Liu, Zhixiang Zuo, Zhizhong Pan, Penghui Zhou, Jian Zheng, Pei-Rong Ding
Summary: DKK1 suppresses the antitumor immune reaction via the GSK3 beta/E2F1/T-bet axis in CD8+ T cells. Elevated serum DKK1 predicts poor tumor response to PD-1 blockade in dMMR/MSI CRCs, and DKK1 neutralization may restore sensitivity to PD-1 blockade.
JOURNAL FOR IMMUNOTHERAPY OF CANCER
(2021)
Article
Oncology
Job P. van Kooten, Arvind Oemrawsingh, Nadine L. de Boer, Cornelis Verhoef, Jacobus W. A. Burger, Eva V. E. Madsen, Alexandra R. M. Brandt-Kerkhof
Summary: This study analyzed the predictive value of postoperative inflammatory biomarkers CRP and WBC in assessing complications after CRS and HIPEC. The results indicated that patients with continuously increasing CRP levels from the second to fifth postoperative day were more likely to develop SAE >= 3 complications. CRP concentrations above 166 mg/L on POD3 and 116 mg/L on POD4 were associated with the highest risk of SAE >= 3, while postoperative WBC levels did not show significant differences between patients with different SAE levels.
ANNALS OF SURGICAL ONCOLOGY
(2021)
Article
Oncology
Florian E. Buisman, Wills F. Filipe, Nancy E. Kemeny, Raja R. Narayan, Rami M. Srouji, Vinod P. Balachandran, Thomas Boerner, Jeffrey A. Drebin, William R. Jarnagin, T. Peter Kingham, Alice C. Wei, Dirk J. Grunhagen, Cornelis Verhoef, Bas Groot Koerkamp, Michael I. D'Angelica
Summary: This study investigated the effectiveness of adjuvant hepatic arterial infusion pump (HAIP) chemotherapy after complete resection or ablation of recurrent colorectal liver metastases and found that adjuvant HAIP is associated with superior hepatic disease-free survival and overall survival.
ANNALS OF SURGICAL ONCOLOGY
(2021)
Article
Radiology, Nuclear Medicine & Medical Imaging
Marjaneh Taghavi, Stefano Trebeschi, Rita Simoes, David B. Meek, Rianne C. J. Beckers, Doenja M. J. Lambregts, Cornelis Verhoef, Janneke B. Houwers, Uulke A. van der Heide, Regina G. H. Beets-Tan, Monique Maas
Summary: A machine learning-based radiomics model was able to predict the occurrence of colorectal liver metastases in patients with colorectal cancer and provide valuable biomarkers for identifying high-risk patients. The predictive models including radiomics features, clinical features, and a combination of both showed promising results with AUC values of 86%, 71%, and 86% in the validation cohort, respectively.
ABDOMINAL RADIOLOGY
(2021)
Review
Oncology
Jeske R. E. Boeding, Winesh Ramphal, Arjen M. Rijken, Rogier M. P. H. Crolla, Cornelis Verhoef, Paul D. Gobardhan, Jennifer M. J. Schreinemakers
Summary: Treatment options for obstructing colon cancer are controversial, with emergency resection resulting in higher mortality and complication rates compared to staged treatment for potentially curable right-sided OCC. Staged treatment appears to have lower mortality rates, fewer complications, and fewer anastomotic leaks and stomas created compared to emergency resection in these patients.
ANNALS OF SURGICAL ONCOLOGY
(2021)
Review
Oncology
Enrico Martin, Ritchie T. J. Geitenbeek, J. Henk Coert, David F. Hanff, Laura H. Graven, Dirk J. Grunhagen, Cornelis Verhoef, Walter Taal
Summary: Noninvasive tests like MRI, FDG-PET, and liquid biopsies are useful for distinguishing MPNST from BPNST, with MRI showing high sensitivity and specificity for certain features, and FDG-PET having an ideal SUVmax threshold of >=3.5 for accuracy.
Article
Clinical Neurology
Enrico Martin, Courtney Pendleton, Cornelis Verhoef, Robert J. Spinner, J. Henk Coert
Summary: This study aimed to investigate postoperative morbidity and the use and outcomes of functional reconstructions in patients with malignant peripheral nerve sheath tumors (MPNSTs). The results showed that the incidence of postoperative motor and sensory deficits is still unknown, and the use of functional reconstructions is infrequent.
Article
Radiology, Nuclear Medicine & Medical Imaging
Martijn P. A. Starmans, Milea J. M. Timbergen, Melissa Vos, Michel Renckens, Dirk J. Grunhagen, Geert J. L. H. van Leenders, Roy S. Dwarkasing, Francois E. J. A. Willemssen, Wiro J. Niessen, Cornelis Verhoef, Stefan Sleijfer, Jacob J. Visser, Stefan Klein
Summary: In this study, radiomics was used to distinguish gastrointestinal stromal tumors (GISTs) from other intra-abdominal tumors and predict the mutational status and mitotic index of GISTs. The results showed that the radiomics model performed similarly to three radiologists in distinguishing GISTs from non-GISTs, but it was less observer dependent. However, the model was unable to predict any genetic or molecular features, limiting its use in treatment planning.
JOURNAL OF DIGITAL IMAGING
(2022)
Article
Oncology
Anne-Rose W. Schut, Emma Lidington, Milea J. M. Timbergen, Eugenie Younger, Winette T. A. van der Graaf, Winan J. van Houdt, Johannes J. Bonenkamp, Robin L. Jones, Dirk. J. Grunhagen, Stefan Sleijfer, Cornelis Verhoef, Spyridon Gennatas, Olga Husson
Summary: Desmoid-type fibromatosis (DTF) is a rare soft-tissue tumor that can negatively impact health-related quality of life (HRQoL). A specific HRQoL tool, the DTF-QoL, was previously developed for assessing DTF-specific issues. This study pre-tested the DTF-QoL and selected 96 questions to form the final questionnaire, which can be used to evaluate HRQoL of DTF patients in clinical and research settings, aiming to personalize care and improve patient experience.
Article
Oncology
Kostandinos Sideras, David W. Hillman, Karthik Giridhar, Brenda F. Ginos, Richard C. Tenglin, Heshan Liu, Beiyun Chen, Winston Tan, Gerald G. Gross, Rex B. Mowat, Amylou C. Dueck, Edith A. Perez, Alvaro Moreno-Aspitia
Summary: Pixantrone showed insufficient activity in refractory HER2-negative MBC patients but appeared to have limited cardiotoxicity. The study was terminated.
Article
Oncology
Gijsbert M. Kalisvaart, Ruben P. J. Meijer, Okker D. Bijlstra, Hidde A. Galema, Wobbe O. de Steur, Henk H. Hartgrink, Cornelis Verhoef, Lioe-Fee de Geus-Oei, Dirk J. Grunhagen, Yvonne M. Schrage, Alexander L. Vahrmeijer, Jos A. van der Hage
Summary: This study assessed the potential and limitations of near-infrared fluorescence imaging with indocyanine green in intraoperative tumor identification of GISTs. The results showed that GISTs typically have similar fluorescence intensity to the surrounding tissue, indicating that intraoperatively administered indocyanine green is currently not suitable for adequate tumor identification.
Article
Oncology
Evalyn E. A. P. Mulder, Iva Johansson, Dirk J. Grunhagen, Dennie Tempel, Barbara Rentroia-Pacheco, Jvalini T. Dwarkasing, Danielle Verver, Antien L. Mooyaart, Astrid A. M. van der Veldt, Marlies Wakkee, Tamar E. C. Nijsten, Cornelis Verhoef, Jan Mattsson, Lars Ny, Loes M. Hollestein, Roger Olofsson Bagge
Summary: This study assessed the performance of a clinicopathologic and gene expression model to identify patients with stage I-II melanoma at risk of disease relapse. The model successfully stratified patients into high risk and low risk groups, suggesting its potential usefulness in clinical practice.
Article
Oncology
Anne-Rose W. Schut, Emma Lidington, Milea J. M. Timbergen, Eugenie Younger, Winette T. A. van der Graaf, Winan J. van Houdt, Johannes J. Bonenkamp, Robin L. Jones, Dirk J. Grunhagen, Stefan Sleijfer, Cornelis Verhoef, Spyridon Gennatas, Olga Husson
Summary: Desmoid-type fibromatosis (DTF) is a rare soft tissue tumor that significantly impacts the health-related quality of life (HRQoL) of patients. This study evaluated HRQoL among different groups of DTF patients and identified factors such as age, sex, presence of comorbidities, and treatment type that were associated with DTF-specific HRQoL.
Article
Oncology
Ibtissam Acem, Veroniek M. van Praag, Cassidy Q. B. Mostert, Robert J. P. van der Wal, Ralph M. L. Neijenhuis, Cornelis Verhoef, Dirk J. Grunhagen, Michiel A. J. van de Sande
Summary: This study aimed to assess the ability of an easy-to-use electronic nose to differentiate between patients with soft tissue sarcoma (STS) and those without STS based on their exhaled breath. It is the first pilot study to show that an electronic nose could serve as a diagnostic tool for STS detection with good performance. Future studies are needed to validate these findings in larger cohorts.
Article
Health Care Sciences & Services
N. J. M. C. Vrancken Peeters, Z. L. R. Kaplan, M. E. Clarijs, M. A. M. Mureau, C. Verhoef, T. van Dalen, O. Husson, L. B. Koppert
Summary: This study examined the long-term effects of axillary treatments on health-related quality of life in breast cancer patients. Except for axillary lymph node dissection (ALND) with axillary radiotherapy, other axillary treatments showed no significant impact on physical and psychosocial wellbeing. Patients who received ALND with radiotherapy experienced a significant decrease in physical and psychosocial wellbeing postoperatively.
QUALITY OF LIFE RESEARCH
(2023)
Article
Surgery
Hidde A. Galema, Tessa M. van Ginhoven, Gaston J. H. Franssen, Johannes Hofland, Claire G. O. T. Bouman, Cornelis Verhoef, Alexander L. Vahrmeijer, Merlijn Hutteman, Denise E. Hilling, Stijn Keereweer
BRITISH JOURNAL OF SURGERY
(2023)